A newly identified genomic target for treating penicillin-resistant Streptococcus pneumoniae is the

A) CaPS: capsular polysaccharides.
B) Ply: pneumolysin toxin.
C) MotB: flagella protein.
D) PGRP: peptidoglycan recognition protein.
E) CbpG: pneumococcal adhesin protein.